These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11908675)
1. Vascular endothelial growth factor and vascular targeting of solid tumors. Brekken RA; Thorpe PE Anticancer Res; 2001; 21(6B):4221-9. PubMed ID: 11908675 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor as a marker of tumor endothelium. Brekken RA; Huang X; King SW; Thorpe PE Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838 [TBL] [Abstract][Full Text] [Related]
4. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex. Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835 [TBL] [Abstract][Full Text] [Related]
5. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104 [TBL] [Abstract][Full Text] [Related]
6. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362 [TBL] [Abstract][Full Text] [Related]
7. VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. Brekken RA; Thorpe PE J Control Release; 2001 Jul; 74(1-3):173-81. PubMed ID: 11489493 [TBL] [Abstract][Full Text] [Related]
8. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. Melnyk O; Zimmerman M; Kim KJ; Shuman M J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768 [TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340 [TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021 [TBL] [Abstract][Full Text] [Related]
12. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855 [TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Pradeep CR; Sunila ES; Kuttan G Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508 [TBL] [Abstract][Full Text] [Related]
14. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450 [TBL] [Abstract][Full Text] [Related]
16. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts. Davis DW; Inoue K; Dinney CP; Hicklin DJ; Abbruzzese JL; McConkey DJ Cancer Res; 2004 Jul; 64(13):4601-10. PubMed ID: 15231672 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor. Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500 [TBL] [Abstract][Full Text] [Related]
20. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep. Petersen W; Unterhauser F; Pufe T; Zantop T; Südkamp NP; Weiler A Arch Orthop Trauma Surg; 2003 May; 123(4):168-74. PubMed ID: 12734715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]